Pharmaceutical Technology

SEPTEMBER 15, 2022

As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. Pfizer reaped $36.8bn from Comirnaty, the highest revenue generated from Covid-19 vaccine sales worldwide. YoY revenue growth.

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

Pharmaceutical Technology

MAY 16, 2023

This growth is expected to continue, with a 62% growth in annual consensus sales forecast from 2023 to 2028, fuelled by the company’s semaglutide portfolio, according to GlobalData’s report, ‘Looking ahead to 2023 – the future of pharma’. Johnson & Johnson maintained its leading position despite a decline of 12.8%

Marketing 52

Marketing Sales Pharma Leads 52

European Pharmaceutical Review

FEBRUARY 8, 2023

GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. It is set to retain its market-leading position as the most lucrative CD19 CAR-T agent in NHL, with annual sales reaching $1.7 Peak sales are anticipated to reach $1.3 billion in 2031.

Marketing 93

Marketing Sales Physicians Patients 93

Sales Talent

FEBRUARY 7, 2020

**The 2022 Sales Hiring Forecast has been released – check it out now!**. It’s time for the 6th installment of our annual sales hiring forecast. As there isn’t a hiring forecast specific for b2b sales roles, we started our own forecast in 2015 to help fill this gap. 2019 Sales Hiring in Review. 2020 Sales Hiring Forecast.

Sales 52

Sales B2B Sales Recruitment Marketing 52

European Pharmaceutical Review

AUGUST 21, 2023

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 Lilly completes biopharma acquisitions GlobalData highlighted that Eli Lilly reported its synthetic peptide Mounjaro had $980 million in global sales in Q2. trillion in the Q1 of 2023 to $3.56

Biopharma 81

Biopharma Marketing Sales Medicine 81

Every Ancillary

MAY 14, 2021

Most seasoned medical sales representatives have carried several different products or services over their careers. Between emerging technologies, expiring patents, and ever-changing insurance coverage, the role of a medical sales professional is to constantly adapt and learn new things. Gives you an area of expertise.

Medical sales 52

Medical sales Medical Sales Insurance 52

World of DTC Marketing

MARCH 17, 2021

Fierce Pharma just reported, “a big question hanging over AbbVie CEO Richard Gonzalez is whether he can lead the Illinois pharma safely through the patent cliff of its revenue cornerstone Humira. sales until at least 2023 because 257 patent filings stand in the way. In fact, Richard Gonzalez, C.E.O.

Pharma 186

Pharma Competition Prescription Doctors 186

Pharmaceutical Technology

MAY 19, 2023

EyePoint Pharmaceuticals will also receive potential royalties on the combined net sales of Iluvien and Yutiq in the US from 2025 to 2028.

Food and Drug Administration 52

Food and Drug Administration Food Pharmaceutical Sales 52

Pharmaceutical Technology

NOVEMBER 8, 2022

These acquisitions could possibly add a minimum of $1bn in sales of Viatris by 2028. This will form the foundation to establish a leading international ophthalmology franchise, expediting work for addressing the unmet needs in the area of ophthalmic diseases. Viatris plans to finance these purchases in cash.

Food and Drug Administration 59

Food and Drug Administration Leads Pharma Food 59

Pharmaceutical Technology

MAY 26, 2023

These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. Checkpoint modulators and cell therapies lead the way in the pre-registration stage, which features no cancer vaccines and oncolytic virus-focused therapies, she added.

Marketing 105

Marketing Physicians Insurance Pharmaceutical 105

Pharmaceutical Technology

AUGUST 16, 2022

In 2019, Daiichi Sankyo entered a global development and commercialisation agreement with AstraZeneca for Daiichi Sankyo’s lead antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), in a deal worth $6.9bn. GlobalData estimates that global annual sales for datopotamab deruxtecan in the NSCLC setting will exceed $500m in 2028.

Food and Drug Administration 59

Food and Drug Administration Sales Patients Food 59

Spotio

APRIL 4, 2023

billion by 2028. Keep reading to learn 10 roofing sales tips you can use to drive more revenue in 2023. These 10 roofing sales tips will put you and your sales team in the best position to succeed. These 10 roofing sales tips will put you and your sales team in the best position to succeed.

Prospecting 52

Prospecting Sales pitches Sales Leads 52

Pharmaceutical Technology

DECEMBER 16, 2022

This therapy is currently in Phase II development and is expected to launch in the US and 5EU in 2027 and 2028, respectively. of 7MM sales. GlobalData’s report also covers a third pipeline candidate, quinagolide, a dopamine receptor antagonist being developed by Ferring Pharmaceuticals.

Marketing 59

Marketing Side effects Sales Safety 59

PM360

SEPTEMBER 21, 2023

Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Pharmaceutical Technology

JANUARY 19, 2023

Antigens such as CD123 and CD33, despite being markers of myeloid cells, are shared with their healthy counterparts, and myeloablation following their depletion often leads to detrimental clinical outcomes. If approved, it could reach sales of $158 million in the 8MM (US, France, Germany, Italy, Spain, the UK, Japan, and China) by 2031.

Marketing 52

Marketing FDA Sales Management 52

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

pharmaphorum

JULY 7, 2022

The latest report – in the Wall Street Journal – says that “advanced talks” are underway that could lead to a $200-plus per share offer that would value Seagen at a massive $40 billion, $10 billion more than earlier estimates.

Pharma 52

Pharma Marketing Sales Medicine 52

European Pharmaceutical Review

NOVEMBER 1, 2023

It is one of the leading causes of death associated with AMR globally. Using this approach, our lead programme – RVX 001, a protein-based vaccine against invasive pneumococcal disease – has been designed with antigens common to all pneumococcus serotypes. References World Health Organization. 2022 [cited May2023].

Safety 96

Safety Marketing Manufacturing Government 96

Medico Reach

JUNE 2, 2022

It also has products from other leading manufacturers. Brasseler USA is one of the leading dental instrumentation companies popular for restorative, orthodontic, endodontic, and oral surgery equipment. They follow a direct sales model and sell their products directly to the customer, without any interference from any middlemen.

Marketing 52

Marketing Manufacturing Distribution Leads 52

PM360

APRIL 7, 2023

Pharma, formulary decision-makers, and contracting specialists must now track exact dates when drugs became available, then track the difference between average sales price (ASP) and Maximum Fair Price (MFP) to ensure provider reimbursement is correct.”

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

pharmaphorum

JANUARY 5, 2023

Recruiting and retaining talent is one of the biggest challenges facing the industry now through 2028, as the US Bureau of Labor Statistics expects life, physical, and social sciences to grow 7%. Address mental health early: Burnout is common amongst professionals in the pharmaceutical industry and leads to high turnover.

Pharmaceutical 62

Pharmaceutical Recruitment Training Education 62

European Pharmaceutical Review

JUNE 27, 2022

According to the ClinicalTrials.gov trial registry, as of April 2022 3 there were 231 bsAbs in clinical trials and a recent industry report 4 predicts the global market revenue for these products will exceed $20 billion by 2028. Figure 1: Example of bi-specific formats. Tools such as the Lonza High?Throughput Nat Rev Drug Discov.

Recruitment 87

Recruitment Manufacturing Media Leads 87

pharmaphorum

AUGUST 2, 2022

According to McKinsey, global oncology sales are expected to hit $250 billion by 2024 and, despite the impact of COVID-19, the number of clinical trials starts reached record highs in 2021, stated IQVIA. billion in revenue last year.

Marketing 87

Marketing Prospecting Sales Pharma 87

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. Non-small cell lung cancer leads as the indication with the highest number of PROTACs in the pipeline, currently sitting at 11 preclinical candidates.

Competition 59

Competition Safety Patients Pharmaceutical 59